Combined with the predicted results of the JASPAR database and previous studies, it is shown that the CITED2 promoter variant leads to the reduction in CITED2 activity, which may be directly involved in the occurrence and development of ASD. This evidence concerns the gene CITED2 and atrial septal defect.